[1]陈伟国,朱萧玲,常 盼,等.芪参益气滴丸对急性心肌梗死PCI术后患者血清学指标及预后的影响*[J].陕西中医,2020,(1):20-23.
 CHEN Weiguo,ZHU Xiaoling,CHANG Pan,et al.Fects of Qishen Yiqi dropping refs on serum indexes and prognosis 〖JZ〗of patients with acute myocardial infarction after PCI[J].,2020,(1):20-23.
点击复制

芪参益气滴丸对急性心肌梗死PCI术后患者血清学指标及预后的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年1期
页码:
20-23
栏目:
临床研究
出版日期:
2020-01-05

文章信息/Info

Title:
Fects of Qishen Yiqi dropping refs on serum indexes and prognosis 〖JZ〗of patients with acute myocardial infarction after PCI
文章编号:
DOI:10.3969/j.issn.10007369.2020.01.005
作者:
陈伟国1朱萧玲1常 盼2王西辉1
1.西安医学院第二附属医院心血管内科(西安710038);2.西安医学院第二附属医院科研科(西安710038)
Author(s):
CHEN Weiguo ZHU XiaolingCHANG Panet al.
Department of Cardiovascular Medicine,〖JZ〗the Second Affiliated Hospital of Xi’an Medical University(Xi’an 710038)
关键词:
芪参益气滴丸急性心肌梗死PCI术血清学指标血管内皮功能预后
Keywords:
Key words 〖WT5BZ〗〖HT5”SS〗Qishen Yiqi dropping refsAcute myocardial infarctionPCI surgerySerological indicatorsVascular endothelial functionThe prognosis
分类号:
R542.22
文献标志码:
A
摘要:
摘 要 目的:探讨芪参益气滴丸对急性心肌梗死PCI术后患者各血清学指标及预后的影响。方法:选取110例急性心肌梗死患者为研究对象,所有患者均接受PCI术治疗,根据入院单双号将受试者分为对照组(n=55)和研究组(n=55),对照组患者术后给予常规西药治疗,研究组患者在对照组的基础上口服芪参益气滴丸治疗,比较两组患者的治疗总有效率、治疗前后各炎性因子水平及各血管内皮功能指标变化,随访1年后,比较两组不良心血管事件发生率。结果:研究组患者治疗总有效率显著高于对照组(P<0.05);与治疗前相比,治疗后两组患者各炎性因子水平均明显降低,且研究组显著低于对照组(P<0.05);与治疗前相比,治疗后两组患者各血管内皮功能指标均明显改善,且研究组显著优于对照组(P<0.05);研究组患者不良心血管事件发生率显著低于对照组(P<0.05)。结论:芪参益气滴丸可有效改善患者的血管内皮功能,抗炎作用显著,减少不良心血管事件发生率,疗效确切,对改善急性心肌梗死PCI术后患者预后具有积极意义。
Abstract:
Abstract 〖WT5BZ〗〖HT5”SS〗Objective:To investigate the effect of Qishen Yiqi dropping refs on the serum indexes and prognosis of patients with acute myocardial infarction after PCI.Methods:110 patients with acute myocardial infarction were selected as research objects,All patients received PCI,The subjects were divided into control group (n=55) and study group (n=55) according to the number of single and even number of admission.Patients in the control group were given conventional western medicine treatment after surgery,and patients in the research group were given Qishen Yiqi dropping refs orally on the basis of the control group.The total effective rate,levels of inflammatory factors and indicators of vascular endothelial function before and after treatment were compared between the two groups.The incidence of adverse cardiovascular events was compared between the two groups after 1year followup.Results:The total effective rate of the study group was significantly higher than that of the control group (P<005);Compared with before treatment,the levels of inflammatory factors in both groups were significantly reduced after treatment,and the study group was significantly lower than the control group (P<0.05);Compared with before and after treatment,all indexes of vascular endothelial function in the two groups were significantly improved,and the research group was significantly better than the control group (P<0.05);The incidence of adverse cardiovascular events in the study group was significantly lower than that in the control group (P<0.05).Conclusion:Qishen Yiqi dropping refs can effectively improve the vascular endothelial function of patients,have significant antiinflammatory effects,reduce the incidence of adverse cardiovascular events,and have definite efficacy,which is of positive significance for improving the prognosis of patients with acute myocardial infarction after PCI.

参考文献/References:

[1] 许明生,张科芝,杨林飞,等.左卡尼汀对急性心肌梗死行急诊PCI术患者血清心肌标志物及短期预后的影响[J].安徽医学,2017,38(3):333335.
[2] 张武宁,彭雪梅,高晓东,等.芪参益气滴丸对首次急性ST段抬高型前壁心肌梗死病人PCI术后hsCRP水平及短期心功能的影响[J].中西医结合心脑血管病杂志,2018,16(11):15431546.
[3] 曹甜甜,张 巍,张 云,等.强心益气方联合瑞舒伐他汀治疗急性心肌梗死的疗效及对患者血清相关指标的影响[J].现代生物医学进展,2017,17(5):866869.
[4] 李 方,贾 玲.心血管疾病诊疗要点手册[M].北京:人民军医出版社,2007:258260.
[5] 同济医科大学.急性心肌梗死的诊断和治疗[M].北京:人民卫生出版社, 2000:3840.
[6] 解 飞.芪参益气滴丸治疗缺血性心肌病心功能不全的综合疗效评价[J].陕西中医,2015,36(7):814815.
[7] 刘 敏,张培影,王忠良.芪参益气滴丸联合心脉通贴散对PCI术后患者临床疗效及炎症因子的影响[J].中国中西医结合杂志,2018,38(9):10491053.
[8] 祁俊仙,袁如玉,李广平,等.冠心病慢性心力衰竭患者血清脂联素水平及芪参益气滴丸对其影响[J].陕西医学杂志,2010,39(12):16241627.
[9] 〖JP3〗陈雪明,陈 健.芪参益气滴丸对冠心病患者血液黏稠度及血管内皮功能的影响[J].医学综述,2016,22(19):38963898.〖JP〗
[10] 谷 丰,杨巧宁,白瑞娜.芪参益气滴丸治疗冠心病介入术后合并高血压患者的预后研究[J].世界中医药,2018,13(10):3034.
[11] 刘 杲,伊争伟,毛亚妮.经皮冠状动脉支架置入术与尿激酶溶栓治疗急性心肌梗死临床疗效及安全性比较[J]. 陕西医学杂志, 2018,47(3):347349,352. 
[12] 李 英,赵丽红.芪苈强心胶囊对ST段抬高型急性心肌梗死PCI术后患者心功能及预后的影响[J].中国医药导报,2018,15(6):137140.
[13] 苏先华,邓桂丽.芪参益气滴丸在老年心肌梗死患者中的应用[J].中国中医急症,2016,25(11):21232125.
[14] 王伊丽,李 澜,徐赟晟,等.芪参益气滴丸在心血管系统疾病模型中的药理作用研究进展[J].天津中医药大学学报,2018,37(2):169172.
[15] 赵 云,陈晓瑞.芪参益气滴丸对老年急性心肌梗死患者超敏C反应蛋白和心脏功能的影响[J].重庆医学,2016,45(10):13791380.

相似文献/References:

[1]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
 YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(1):437.
[2]刘耀武.四逆汤联合溶栓治疗急性心肌梗死缺血再灌注损伤及对患者动态心电图和SOD、CK-MB、LDH的影响[J].陕西中医,2019,(7):858.
[3]范国萍,闫新慧.通络养心汤对急性心肌梗死经皮冠状动脉介入术后高缺血风险患者血小板抑制率及出血事件的影响*[J].陕西中医,2019,(8):1025.
 FAN Guoping,YAN Xinhui..Effect of Tongluo Yangxin decoction in treating acute myocardial infarction combined with high risk of ischemia and evaluate the platelet inhibition rate and hemorrhage events risk[J].,2019,(1):1025.
[4]宋金玉,杜 鑫,施继红,等.芪苈强心胶囊联合米力农对心肌梗死合并心力衰竭患者动脉血流和心功能的影响*[J].陕西中医,2020,(4):493.
[5]王朝歆,李 岩,王 超,等.芎归六君子汤治疗急性心肌梗死疗效及对患者再灌注损伤后心功能、氧化应激水平的影响[J].陕西中医,2021,(11):1549.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.012]
 WANG Chaoxin,LI Yan,WANG Chao,et al.Effect of Xionggui Liujunzi decoction on cardiac function and oxidative stress level in patients with acute myocardial infarction after reperfusion injury[J].,2021,(1):1549.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.012]
[6]李倩宇,卢健棋,温志浩,等.基于PI3K/Akt通路探讨补阳还五汤对急性心肌梗死大鼠内皮祖细胞凋亡的影响[J].陕西中医,2023,(7):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]
 LI Qianyu,LU Jianqi,WEN Zhihao,et al.Effect of Buyang Huanwu prescription on apoptosis of endothelial progenitor cells in rats with acute myocardial infarction based on PI3K/Akt pathway[J].,2023,(1):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81670365) 陕西省重点研发计划项目(2018SF129)
更新日期/Last Update: 2020-02-17